DE69524103T2 - Fluorinierte 2-nitroimidazole analoge zur detektion von hypoxischen tumorzellen - Google Patents
Fluorinierte 2-nitroimidazole analoge zur detektion von hypoxischen tumorzellenInfo
- Publication number
- DE69524103T2 DE69524103T2 DE69524103T DE69524103T DE69524103T2 DE 69524103 T2 DE69524103 T2 DE 69524103T2 DE 69524103 T DE69524103 T DE 69524103T DE 69524103 T DE69524103 T DE 69524103T DE 69524103 T2 DE69524103 T2 DE 69524103T2
- Authority
- DE
- Germany
- Prior art keywords
- tumor cells
- hypoxic tumor
- fluorinated
- detecting hypoxic
- nitroimidazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Crystallography & Structural Chemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28647794A | 1994-08-05 | 1994-08-05 | |
US08/458,178 US5721265A (en) | 1994-08-05 | 1995-06-02 | Fluorinated 2-nitroimidazole analogs for detecting hypoxic tumor cells |
PCT/US1995/009611 WO1996004249A1 (en) | 1994-08-05 | 1995-07-31 | Fluorinated 2-nitroimidazole analogs for detecting hypoxic tumor cells |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69524103D1 DE69524103D1 (de) | 2002-01-03 |
DE69524103T2 true DE69524103T2 (de) | 2002-07-18 |
Family
ID=26963851
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69524103T Expired - Fee Related DE69524103T2 (de) | 1994-08-05 | 1995-07-31 | Fluorinierte 2-nitroimidazole analoge zur detektion von hypoxischen tumorzellen |
Country Status (10)
Country | Link |
---|---|
US (1) | US5721265A (de) |
EP (1) | EP0775117B1 (de) |
JP (1) | JP3872511B2 (de) |
AT (1) | ATE209187T1 (de) |
CA (1) | CA2196900C (de) |
DE (1) | DE69524103T2 (de) |
DK (1) | DK0775117T3 (de) |
ES (1) | ES2165430T3 (de) |
PT (1) | PT775117E (de) |
WO (1) | WO1996004249A1 (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6855828B1 (en) | 1992-11-19 | 2005-02-15 | The Trustees Of The University Of Pennsylvania | Detection of hypoxia |
US6252087B1 (en) * | 1992-11-19 | 2001-06-26 | The Trustees Of The University Of Pennsylvania | Nitroaromatic compounds for the detection of hypoxia |
US20050026974A1 (en) * | 1996-02-08 | 2005-02-03 | Trustees Of The University Of Pennsylvania | Detection of hypoxia |
ES2123449B1 (es) * | 1997-03-06 | 1999-09-16 | Univ Madrid Nac Educacion | Procedimiento para la obtencion de imagenes y espectros del ph extracelular por resonancia magnetica con indicadores extrinsecos conteniendo 1h o 19f. |
EP1015471A1 (de) * | 1997-08-21 | 2000-07-05 | Quark Biotech, Inc. | Hypoxieregulierte gene |
CA2345108A1 (en) * | 1998-09-25 | 2000-04-06 | Monsanto Company | Substituted n-aliphatic-n-aromatic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
WO2001007414A1 (en) * | 1999-07-21 | 2001-02-01 | The Trustees Of The University Of Pennsylvania | Preparation of compounds useful for the detection of hypoxia |
US7230115B1 (en) | 1999-07-21 | 2007-06-12 | The Trustees Of The University Of Pennsylvania | Preparation of compounds useful for the detection of hypoxia |
US20010018446A1 (en) | 1999-09-23 | 2001-08-30 | G.D. Searle & Co. | Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
CA2400092A1 (en) * | 2000-02-14 | 2001-08-16 | Virexx Research, Inc. | Diagnostic and therapeutic compositions and methods for affecting tumor growth using oxygen mimetic agents |
DE102005063244A1 (de) * | 2005-12-21 | 2007-06-28 | Eberhard-Karls-Universität Tübingen | Modifiziertes 2-Nitroimidazol-Derivat |
US9056136B2 (en) * | 2006-10-06 | 2015-06-16 | Natural Pharmacia International, Inc. | Weakly basic 2-nitroimidazoles for the non-invasive detection of tissue hypoxia |
KR101523257B1 (ko) * | 2007-04-05 | 2015-05-27 | 쓰레솔드 파마슈티컬스, 인코포레이티드 | 니트로-이미다졸 저산소증 영상화제 |
EP2123620A1 (de) * | 2008-05-20 | 2009-11-25 | Bayer Schering Pharma Aktiengesellschaft | {F-19}-markierte L-Glutaminsäure und L-Glutaminderivat (III), Verwendung davon und Verfahren zu deren Erhalt |
WO2010073126A2 (en) * | 2008-12-22 | 2010-07-01 | The Governors Of The University Of Alberta | Compounds useful in delivering anti-neoplastic therapy and diagnostic imaging to hypoxic cells and methods of use thereof |
CN101624392B (zh) * | 2009-08-10 | 2014-07-09 | 北京师范大学 | F-三唑环-聚乙二醇-2-硝基咪唑化合物及其制备方法 |
WO2011068537A2 (en) | 2009-12-01 | 2011-06-09 | Fraser Cassandra L | Mechanochromic luminescent difluoroboron beta-diketonates |
CN113501789B (zh) * | 2021-06-16 | 2023-03-31 | 首都医科大学脑重大疾病研究中心(北京脑重大疾病研究院) | 一种硝基咪唑类衍生物及其制备方法和应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3505349A (en) * | 1966-04-18 | 1970-04-07 | Hoffmann La Roche | 2-nitro-imidazolyl-1-acetamides |
CA1329206C (en) * | 1987-06-10 | 1994-05-03 | Tsutomu Kagiya | Fluorine-containing nitroazole derivatives and radiosensitizer comprising the same |
US5304654A (en) * | 1987-06-10 | 1994-04-19 | Yasunori Nishijima | Fluorine-containing nitroimidazole compounds |
IL92597A0 (en) * | 1988-12-14 | 1990-08-31 | Yasunori Nishijima President K | Novel fluorine-containing 2-nitroimidazole derivatives and radiosensitizer comprising the same |
JP4169782B2 (ja) * | 1992-11-19 | 2008-10-22 | ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア | 低酸素症の検出 |
-
1995
- 1995-06-02 US US08/458,178 patent/US5721265A/en not_active Expired - Fee Related
- 1995-07-31 WO PCT/US1995/009611 patent/WO1996004249A1/en active IP Right Grant
- 1995-07-31 DE DE69524103T patent/DE69524103T2/de not_active Expired - Fee Related
- 1995-07-31 ES ES95927535T patent/ES2165430T3/es not_active Expired - Lifetime
- 1995-07-31 PT PT95927535T patent/PT775117E/pt unknown
- 1995-07-31 CA CA002196900A patent/CA2196900C/en not_active Expired - Fee Related
- 1995-07-31 DK DK95927535T patent/DK0775117T3/da active
- 1995-07-31 EP EP95927535A patent/EP0775117B1/de not_active Expired - Lifetime
- 1995-07-31 AT AT95927535T patent/ATE209187T1/de not_active IP Right Cessation
- 1995-07-31 JP JP50666096A patent/JP3872511B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ATE209187T1 (de) | 2001-12-15 |
EP0775117A1 (de) | 1997-05-28 |
JPH10506104A (ja) | 1998-06-16 |
CA2196900C (en) | 2009-02-24 |
WO1996004249A1 (en) | 1996-02-15 |
JP3872511B2 (ja) | 2007-01-24 |
ES2165430T3 (es) | 2002-03-16 |
PT775117E (pt) | 2002-05-31 |
CA2196900A1 (en) | 1996-02-15 |
DE69524103D1 (de) | 2002-01-03 |
DK0775117T3 (da) | 2002-05-21 |
EP0775117B1 (de) | 2001-11-21 |
US5721265A (en) | 1998-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69524103D1 (de) | Fluorinierte 2-nitroimidazole analoge zur detektion von hypoxischen tumorzellen | |
ES477695A1 (es) | Un procedimiento para preparar derivados de deshidrociclici-minoacidos. | |
SE7906533L (sv) | Pyrrolidinderivat | |
TR200102800T2 (tr) | Yeni bileşikler. | |
DK142985D0 (da) | Redox-indikatorer | |
ATE323678T1 (de) | Tri-aryl-säurederivate als ppar rezeptor liganden | |
ATE301122T1 (de) | Kernerweiterte perylenbisimide und ihre verwendung als fluoreszenzfarbstoffe | |
ATE249440T1 (de) | Flüssige benzisochinoline derivate | |
ES2193241T3 (es) | Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas. | |
DK148183A (da) | Fremgangsmaade til fremstilling af imidazolylphenyl-tetrahydropyridaziner | |
ES2081636T3 (es) | Preparacion de piperidinas sustituidas. | |
ATE48835T1 (de) | Chinolylglycinamidderivate, verfahren zu ihrer herstellung und therapeutische verwendung als psychotrope. | |
ATE30719T1 (de) | Imino-2-pyrrolidine, verfahren zu ihrer herstellung und ihre therapeutische verwendung. | |
ES466851A1 (es) | Procedimiento para la preparacion de 2-bromo-6-fluor-n-2- imidazolidinilidenbenzamina. | |
EA199900754A1 (ru) | Способ получения замещенного тиазолидиндиона | |
DK0871612T3 (da) | Kondenserede isoindoloner som proteinkinase C-inhibitorer | |
ATE153657T1 (de) | Cyclische benzylamino-, benzylamido- und benzylimido derivate als antipsychotische wirkstoffe | |
GR3003656T3 (de) | ||
ES2043784T3 (es) | Procedimiento de preparacion de compuestos guanidinicos. | |
DK0426557T3 (da) | Fremgangsmåde til fremstilling af (1R,2R)-2-(3-pyridyl)tetrahydrothiopyran-2-carbothioamid-1-oxider, mellemprodukter anvendt ved denne fremgangsmåde og fremstilling af disse mellemprodukter | |
ATE33837T1 (de) | Azolylmethylcycloacetale, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
FI960588A0 (fi) | Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä | |
DK0555283T3 (da) | Mellemprodukter ved fremstillingen af 4,5-difluoranthranilinsyre | |
ATE85604T1 (de) | Verfahren zur herstellung von 4-bromanilinhydrobromiden. | |
AU558025B2 (en) | Dithiino(1,4)(2,3-6)pyrrole derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: SRI INTERNATIONAL, MENLO PARK, CALIF., US Owner name: CANCER RESEARCH CAMPAIGN TECHNOLOGY LTD., LONDON, |
|
8339 | Ceased/non-payment of the annual fee |